The global medical cannabis market is no longer a niche sector. As of 2025, more than 50 countries have enacted legal frameworks permitting some form of…
Read MoreLuxembourg’s Home Grow Model: What 4 Plants Per Household Means for European Cannabis Policy
When Luxembourg’s Law of 10 July 2023 entered into force on 21 July 2023, it was easy to read as a minor footnote in a year dominated by Germany’s landmark…
Read MoreAfrica’s Cannabis Frontier: South Africa’s Permit Landscape and Lesotho’s Export Ambitions
Africa’s cannabis story is being written from two flanks simultaneously. In Pretoria, a multi-departmental government machine is turning a National Cannabis…
Read MoreBrazil Opens the Export Door: ANVISA Authorizes Medicinal Cannabis IFA Exports Under RDC 1.023/2026
Brazil’s ANVISA has published RDC 1.023/2026, authorizing the export of medicinal-cannabis active pharmaceutical ingredients (IFAs) produced in Brazil. Here is what it means for producers.
Read MoreLatin America’s Cannabis Market Transformation: $440M Today, $1B+ by 2028
The $440 million figure demands attention. Latin America’s legal cannabis market reached that valuation in 2024 — a 50% single-year increase — and analysts…
Read MoreNew Zealand’s Medicinal Cannabis Supply Grows 14x: From CBD Oils to THC-Dominant Flower
When New Zealand’s Medicinal Cannabis Scheme commenced on 1 April 2020, the country’s entire quarterly market amounted to 4,827 packs — a handful of CBD oils…
Read More